Norges Bank’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $359M | Sell |
|
|||||
|
2021
Q1 | $340M | Sell |
|
|||||
|
2020
Q4 | $495M | Sell |
|
|||||
|
2020
Q3 | $402M | Sell |
|
|||||
|
2020
Q2 | $401M | Buy |
|
|||||
|
2020
Q1 | $289M | Buy |
|
|||||
|
2019
Q4 | $340M | Buy |
|
|||||
|
2019
Q3 | $291M | Sell |
|
|||||
|
2019
Q2 | $396M | Buy |
|
|||||
|
2019
Q1 | $389M | Sell |
|
|||||
|
2018
Q4 | $389M | Buy |
|
|||||
|
2018
Q3 | $507M | Sell |
|
|||||
|
2018
Q2 | $458M | Sell |
|
|||||
|
2018
Q1 | $420M | Buy |
|
|||||
|
2017
Q4 | $426M | Buy |
|
|||||
|
2017
Q3 | $489M | Sell |
|
|||||
|
2017
Q2 | $456M | Buy |
|
|||||
|
2017
Q1 | $374M | Buy |
|
|||||
|
2016
Q4 | $256M | Buy |
|
|||||
|
2016
Q3 | $219M | Buy |
|
|||||
|
2016
Q2 | $194M | Buy |
|
|||||
|
2016
Q1 | $228M | Sell |
|
|||||
|
2015
Q4 | $326M | Buy |
|
|||||
|
2015
Q3 | $262M | Buy |
|
|||||
|
2015
Q2 | $280M | Buy |
|
|||||
|
2015
Q1 | $226M | Sell |
|
|||||
|
2014
Q4 | $254M | Buy |
|
|||||
|
2014
Q3 | $222M | Sell |
|
|||||
|
2014
Q2 | $416M | Buy |
|
|||||
|
2014
Q1 | $202M | Buy |
|
|||||
|
2013
Q4 | $173M | Sell |
|
|||||
|
2013
Q3 | $163M | Sell |
|
|||||
|
2013
Q2 | $137M | Buy |
|